Stoke Therapeutics STOK
NASDAQ STOK
$25.98 -0.03 (-0.12%)
As of: Oct 2, 2026 · 11:57 AM EDT

Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Stoke Therapeutics (STOK) reported Net Equity Issued and Repurchased of $1.91 million for Q2 2026, up 245.1% from $554,000 a year earlier but down 40.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Stoke Therapeutics' Net Equity Issued and Repurchased came in at $12.16 million, up 437.2% year-over-year; for FY2025, it came in at $8.6 million, up 399.6% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -39.4% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $1.72 million in FY2024 (+210.3%), $555,000 in FY2023 (-2.6%), $570,000 in FY2022 (-26.6%) and $777,000 in FY2021 (-99.3%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $1,000 in Q4 2023 and a high of $4.56 million in Q4 2025.
  • Year over year, Net Equity Issued and Repurchased has now increased in each of the last three quarters, with growth averaging 230.3% over the last six quarters.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2025 (growth of 703.7%); the low point was Q4 2021 (a decline of 99.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.21 million (Q1 2026), $4.56 million (Q4 2025) and $2.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 1.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.91 Mn
Mar 31, 2026 3.21 Mn
Dec 31, 2025 4.56 Mn
Sep 30, 2025 2.49 Mn
Jun 30, 2025 554,000.00
Mar 31, 2025 1.00 Mn
Dec 31, 2024 567,000.00
Sep 30, 2024 139,000.00
Jun 30, 2024 766,000.00
Mar 31, 2024 250,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 348,000.00
Jun 30, 2023 48,000.00
Mar 31, 2023 158,000.00
Sep 30, 2022 151,000.00
Jun 30, 2022 250,000.00
Mar 31, 2022 169,000.00
Dec 31, 2021 172,000.00
Sep 30, 2021 73,000.00
Jun 30, 2021 161,000.00
API Access

Stoke Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=STOK&period=max&api_key=YOUR_API_KEY